Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 334

1.

A placebo-controlled trial of risperidone in Tourette syndrome.

Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS.

Neurology. 2003 Apr 8;60(7):1130-5.

PMID:
12682319
[PubMed - indexed for MEDLINE]
2.

A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.

Nicolson R, Craven-Thuss B, Smith J, McKinlay BD, Castellanos FX.

J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):640-6.

PMID:
15968232
[PubMed - indexed for MEDLINE]
3.

Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.

Cui YH, Zheng Y, Yang YP, Liu J, Li J.

J Child Adolesc Psychopharmacol. 2010 Aug;20(4):291-8. doi: 10.1089/cap.2009.0125.

PMID:
20807067
[PubMed - indexed for MEDLINE]
4.

Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.

Singer HS, Wendlandt J, Krieger M, Giuliano J.

Neurology. 2001 Mar 13;56(5):599-604.

PMID:
11245709
[PubMed - indexed for MEDLINE]
5.

Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.

Kim BN, Lee CB, Hwang JW, Shin MS, Cho SC.

J Child Adolesc Psychopharmacol. 2005 Apr;15(2):318-24.

PMID:
15910216
[PubMed - indexed for MEDLINE]
6.

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF.

J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1147-52. Erratum in: J Am Acad Child Adolesc Psychiatry 1996 Mar;35(3):394.

PMID:
7559308
[PubMed - indexed for MEDLINE]
7.

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.

Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S.

J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):330-6.

PMID:
11886028
[PubMed - indexed for MEDLINE]
8.

Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM.

J Clin Psychiatry. 2003 Apr;64(4):459-65.

PMID:
12716250
[PubMed - indexed for MEDLINE]
9.

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.

McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.

Arch Gen Psychiatry. 1998 Jul;55(7):633-41.

PMID:
9672054
[PubMed - indexed for MEDLINE]
10.

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.

Hirschfeld RM, Keck PE Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F.

Am J Psychiatry. 2004 Jun;161(6):1057-65.

PMID:
15169694
[PubMed - indexed for MEDLINE]
11.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
[PubMed - indexed for MEDLINE]
12.

Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial.

Dion Y, Annable L, Sandor P, Chouinard G.

J Clin Psychopharmacol. 2002 Feb;22(1):31-9.

PMID:
11799340
[PubMed - indexed for MEDLINE]
13.

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.

Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.

Bipolar Disord. 2009 Nov;11(7):687-700. doi: 10.1111/j.1399-5618.2009.00750.x.

PMID:
19839994
[PubMed - indexed for MEDLINE]
14.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
[PubMed - indexed for MEDLINE]
15.

A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.

Reyes M, Buitelaar J, Toren P, Augustyns I, Eerdekens M.

Am J Psychiatry. 2006 Mar;163(3):402-10.

PMID:
16513860
[PubMed - indexed for MEDLINE]
16.

Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.

Gilbert DL, Batterson JR, Sethuraman G, Sallee FR.

J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):206-14.

PMID:
14726728
[PubMed - indexed for MEDLINE]
17.

A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.

Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS.

Mov Disord. 2007 Sep 15;22(12):1764-70.

PMID:
17566124
[PubMed - indexed for MEDLINE]
18.

Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.

Hoekstra PJ, Minderaa RB, Kallenberg CG.

J Clin Psychiatry. 2004 Apr;65(4):537-42.

PMID:
15119917
[PubMed - indexed for MEDLINE]
20.

Tic reduction with pergolide in a randomized controlled trial in children.

Gilbert DL, Dure L, Sethuraman G, Raab D, Lane J, Sallee FR.

Neurology. 2003 Feb 25;60(4):606-11.

PMID:
12601100
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk